WEDNESDAY, May 14, 2025 (HealthDay News) — More U.S. teenagers are getting weight-loss surgery, despite the discovery of new drugs like Ozempic/Wegovy that help people drop pounds surgery-free, a new study says. Weight loss surgeries for teens increased 15% between 2021 and 2023, researchers reported earlier this month in TheContinue Reading
TUESDAY, May 13, 2025 (HealthDay News) — Cutting-edge weight-loss drugs like Ozempic/Wegovy can cut alcohol intake dramatically in a short amount of time, a new study says. People taking semaglutide or liraglutide reduced their alcohol consumption by two-thirds within four months, according to results recently published in the journal Diabetes,Continue Reading
MONDAY, May 12, 2025 (HealthDay News) — A new study has found that people taking Eli Lilly’s obesity drug Zepbound lost almost 50% more weight than those using Novo Nordisk’s Wegovy. The study — published May 11 in the New England Journal of Medicine — followed 751 people across theContinue Reading
FRIDAY, May 9, 2025 (HealthDay News) — Childhood obesity nearly triples a person’s risk for experiencing discrimination or stigma based on their weight, a new study says. Severe obesity before age 18 increased a person’s odds of experiencing weight stigma by 2.8 times, researchers reported recently in the International JournalContinue Reading
SUNDAY, May 4, 2025 (HealthDay News) — Body Mass Index, or BMI, is a number that reflects the relationship between your height and weight. It’s widely used in healthcare and public health to categorize body size and estimate potential risk for weight-related diseases. While it isn’t perfect, BMI can beContinue Reading
FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug, orforglipron, helped people with type 2 diabetes lower their blood sugar and lose weight. The company is hopingContinue Reading
TUESDAY, April 15, 2025 (HealthDay News) — Pfizer has stopped developing a once-daily pill to treat obesity after a person in a clinical trial showed signs of a possible liver injury. The company said the injury went away after the person stopped taking the drug, called danuglipron, The Associated PressContinue Reading
MONDAY, April 7, 2025 (HealthDay News) — The Trump administration has decided not to expand Medicare and Medicaid coverage for popular obesity drugs, blocking a Biden administration initiative that could have helped millions of Americans access the medications. Catherine Howden, a spokeswoman for the Centers for Medicare and Medicaid ServicesContinue Reading
WEDNESDAY, April 2, 2025 (HealthDay News) — The telehealth company Hims & Hers Health is expanding its weight-loss offerings by adding new medications to its platform. The company said Tuesday it now provides access to Zepbound, a brand-name version of the drug tirzepatide, as well as to generic liraglutide. ZepboundContinue Reading
TUESDAY, April 1, 2025 (HealthDay News) — Fasting every other day can prompt more weight loss than simply cutting calories, a new clinical trial shows. People who undertook 4:3 intermittent fasting lost just under 8% of their body weight within a year, compared to a 5% loss among people whoContinue Reading